John W Frew

About

Clinical Dermatologist and Dermatologic Researcher. Special Interests in Hidradenitis Suppurativa.

Employment

• Liverpool Hospital
  2020 - Present
• Rockefeller University Hospital Instructor in Clinical Investigation
  2018 - Present
• University of New South Wales Conjoint Lecturer
  2017 - Present
• Liverpool Hospital Staff Specialist Dermatologist
  2017 - 2018

Education

• Rockefeller University Masters of Science
  2018 - Present
• University of Sydney Masters of Medicine (Clinical Epidemiology)
  2010 - 2011
• University of New South Wales Bachelor of Medicine / Bachelor of Surgery
  2004 - 2009

Projects & Funding

Projects & funding information is unavailable.

Publications (181)

• Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study
  Journal of the European Academy of Dermatology and Venereology 2026 DOI: 10.1111/jdv.70594
  +Save
• Predictors of Survival and Length of Stay in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Single-Center Retrospective Study of 111 Patients
  Journal of Burn Care & Research 2026 DOI: 10.1093/jbcr/irag037
  +Save
• Efficacy of Biologics for Hidradenitis Suppurativa: A Network Meta Analysis and Meta Regression for Baseline Disease Severity
  Australasian Journal of Dermatology 2026 DOI: 10.1111/ajd.70085
  +Save
• Pyoderma Gangrenosum: A Retrospective Cohort Study of Comorbidities and Therapies in Over 65,000 Patients in the TriNetX Database
  JEADV Clinical Practice 2026 DOI: 10.1002/jvc2.70346
  +Save
• Prevalence and predictors of posttraumatic stress disorder in Stevens Johnson syndrome and toxic epidermal necrolysis
  Journal of the European Academy of Dermatology and Venereology 2026 DOI: 10.1111/jdv.20891
  +Save
• Real‐World Efficacy and Drug Survival of Adalimumab in Australian Patients With Psoriasis
  Australasian Journal of Dermatology 2026 DOI: 10.1111/ajd.70024
  +Save
• Psychological Complications of Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta‐Analysis
  Australasian Journal of Dermatology 2025 DOI: 10.1111/ajd.14613
  +Save
• Sequencing of Biologic Therapy in Hidradenitis Suppurativa: A Real‐World Analysis of Treatment in Over 15,000 Patients
  JEADV Clinical Practice 2025 DOI: 10.1002/jvc2.70083
  +Save
• Time to Recognise Psoriasis as a Cardiovascular Risk Modifier in National Guidance
  Australasian Journal of Dermatology 2025 DOI: 10.1111/ajd.14587
  +Save
• Quantifying time to medical and/or surgical therapy after diagnosis of hidradenitis suppurativa and pilonidal sinus disease: A propensity‐matched real‐world cohort analysis
  Journal of the European Academy of Dermatology and Venereology 2025 DOI: 10.1111/jdv.20494
  +Save